1 / 9

VACCINE INITIATIVES ON THE RISE

IMMUNIZATION INITIATIVE FOR THE AGING : A TIME FOR ACTION ? MICHAEL WALDHOLZ PULITZER-PRIZE WINNING HEALTH JOURNALIST. VACCINE INITIATIVES ON THE RISE. VACCINES AS GLOBAL TOOL FOR COST-EFFECTIVE DISEASE PREVENTION  THE DECADE OF VACCINES COLLABORATION

calum
Download Presentation

VACCINE INITIATIVES ON THE RISE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IMMUNIZATION INITIATIVEFOR THE AGING:A TIME FOR ACTION?MICHAEL WALDHOLZPULITZER-PRIZE WINNING HEALTH JOURNALIST

  2. VACCINE INITIATIVES ON THE RISE • VACCINES AS GLOBAL TOOL FOR COST-EFFECTIVE DISEASE PREVENTION •  THE DECADE OF VACCINES COLLABORATION • 10-Year Global Vaccine Action Plan – 2012 World Health Assembly Presentation • THE GAVI ALLIANCE MODEL FOR INCREASING VACCINE COVERAGE FOR CHILDREN • INDUSTRY INNOVATION • GROUP OF EIGHT (G8) REAFFIRMS SUPPORT FOR GAVI APPROACH • UN-WHO World Health Day on Aging, April 2012

  3. “In the same way that during my Microsoft career I talked about the magic of software, I now spend my time talking about the magic of vaccines. They are the most effective and cost-effective health tools ever invented. I like to say vaccines are a miracle’’ Bill Gates, The Bill & Melinda Gates Foundation

  4. THE GAVI MODEL 2000-2012 • 326 Million Additional Children Immunized • Prevented Death of 5 Million Children • Gates Commitment • $10 Billion over Next 10 Years to Prevent 7.6 Million Additional Deaths by 2019 • Unique Financing • $7.2 Billion Pledged Since 2000 • $3.6 Billion Raised in Capital Markets • Innovative Vaccine Production Incentives • Low-Priced Vaccine Production by Additional Countries China, Brazil, Russia, India • Vaccines Procured at Significant Discount

  5. VACCINES FOR THE AGING • Influenza • Pneumococcal • Shingles (Herpes Zoster) • Diphtheria Tetanus Pertussis (DPT) • Yellow Fever • Malaria • Alzheimer’s Disease

  6. DEMOGRAPHIC EXPLOSION 2010-2040 In Richer Nations • Aged 65-70 to Rise to 207 Million from 142 Million • Over Age 80 to Double to 105 Million In Developing Nations • Aged 65-70 to Triple to 752 million • Over Age 80 to Quadruple to 198 million 80% of World’s 60+ Population will be in Lower/Middle-Income Nations

  7. NEED FOR INCREASED VACCINE COVERAGE FOR AGING • Compromised health status of aging populations Decreased Immune Function Co-Morbidities • Cost US: 2010 Pneumonia-Related Costs at $5.5 Billion Europe: Estimated at 10 Billion Euros • ``Little Progress In Improving Adult Coverage in Past Year Highlights Need for Efforts to Increase Coverage’’ 2011 Report by US Centers for Disease Control • Global Vaccine Action Plan Presented to World Health Assembly  ``Life Course’’ Approach Recommended though Focus Mostly on Childhood Immunization • Pneumococcal Vaccine Coverage in US for Over 65 is 60% • Initiatives Aimed Mostly at Childhood Coverage

  8. PROVEN BENEFIT OF VACCINE CAMPAIGNS • Seattle: 10-YEAR Influenza Campaign • 27% at risk of influenza • Results: 48% reduction in death • Turkey: Increased Coverage Rate to 40-60% from 2% • Results: Gain in Life-Years, Reduced Hospitalizations • Spain: Influenza Vaccine Campaign • Results: Employee Absenteeism Reduced 23% • One Euro Invested Saved Four Euros in Absenteeism Costs • Additional Benefits • Herd Immunity • Innovation Encouraged • Lower-Priced Vaccines

  9. POTENTIAL FUTURE INITIATIVES • New Studies Needed to Show Cost-Benefit and Mortality and Morbidity Benefit • Physician Outreach and Tracking • Health Department Initiatives • Public Awareness • GAVI-like Initiative and Gates-like Champion • Industry Action – Innovation, Pricing • Global-Regional Calls to Action

More Related